🔎 Trials Near Me

Hjem › Gliom › District of Columbia › Washington

Kliniske studier for Gliom i Washington, DC

19 studier for Gliom søker deltakere på steder i og rundt Washington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

RekruttererFase 1/2
  • Children's National Medical Center, Washington D.C.
12 Months – 21 Years · Alle kjønn · Oppdatert 1. okt. 2026 · NCT05099003

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

RekruttererFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 99 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07416188

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

RekruttererFase 2
  • Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07326566

ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · Alle kjønn · Oppdatert 21. sep. 2026 · NCT06838676

NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors

RekruttererFase 1
  • Children's National Hospital, Washington D.C.
Alder 3 til 25 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07664176

Targeted Pediatric High-Grade Glioma Therapy

RekruttererObservasjonsstudie
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · Alle kjønn · Oppdatert 8. sep. 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
Alder 12 til 39 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT06161974

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

RekruttererFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 15 og eldre · Alle kjønn · Oppdatert 28. aug. 2026 · NCT05588141

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
Alder 3 til 39 · Alle kjønn · Oppdatert 24. aug. 2026 · NCT05096481

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

RekruttererFase 1
  • Children's National Medical Center, Washington D.C.
Alder 1 til 25 · Alle kjønn · Oppdatert 18. aug. 2026 · NCT04485559

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

RekruttererFase 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 120 · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06344130

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

RekruttererFase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi unna
Alder 18 til 120 · Alle kjønn · Oppdatert 12. aug. 2026 · NCT06161519

MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas

RekruttererFase 1/2
  • Children's National Hospital, Washington D.C.
Alder 1 til 26 · Alle kjønn · Oppdatert 10. jul. 2026 · NCT06712875

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

RekruttererTidlig fase 1Frivillige helsepersonell ønskes velkommen
  • Children's National Medical Center, Washington D.C.
Alder 1 til 21 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT06333899

A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)

RekruttererFase 1
  • Children's National Hospital, Washington D.C.
Alder 4 og eldre · Alle kjønn · Oppdatert 25. jun. 2026 · NCT04573140

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

RekruttererFase 2
  • Children's National Medical Center, Washington D.C.
12 Months – 39 Years · Alle kjønn · Oppdatert 29. mai 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

RekruttererFase 1/2
  • Sibley Memorial Hospital, Washington D.C.
Alder 18 og eldre · Alle kjønn · Oppdatert 13. apr. 2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

RekruttererTidlig fase 1
  • Children's National Medical Center, Washington D.C.
Opp til 21 år · Alle kjønn · Oppdatert 18. mar. 2026 · NCT04655404

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

RekruttererFase 1
  • National Institutes of Health, Bethesda · 7 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 18. des. 2025 · NCT04541082

Gliom-studier i andre byer

Andre studier i Washington

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.